Here we report that RAC1B, but not the conventional RAC1 isoform RAC1A, promotes tumor development, stabilizes EGFR, and can serve as an ideal therapeutic target in EGFR‐mutant LUAD (Figure 7K). This evidence concerns the gene RAC1 and neoplasm.